BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 29161935)

  • 1. Extended Versus Short-Course Corticosteroid Taper Regimens in the Management of Chronic Obstructive Pulmonary Disease Exacerbations in Critically Ill Patients.
    Poon T; Paris DG; Aitken SL; Patrawalla P; Bondarsky E; Altshuler J
    J Intensive Care Med; 2020 Mar; 35(3):257-263. PubMed ID: 29161935
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes associated with corticosteroid dosage in critically ill patients with acute exacerbations of chronic obstructive pulmonary disease.
    Kiser TH; Allen RR; Valuck RJ; Moss M; Vandivier RW
    Am J Respir Crit Care Med; 2014 May; 189(9):1052-64. PubMed ID: 24617842
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of different corticosteroid regimes for hospitalised patients with exacerbated COPD: pooled analysis of individual participant data from the REDUCE and CORTICO-COP trials.
    Sivapalan P; Rutishauser J; Ulrik CS; Leuppi JD; Pedersen L; Mueller B; Eklöf J; Biering-Sørensen T; Gottlieb V; Armbruster K; Janner J; Moberg M; Lapperre TS; Nielsen TL; Browatzki A; Mathioudakis A; Vestbo J; Schüetz P; Jensen JU
    Respir Res; 2021 May; 22(1):155. PubMed ID: 34020641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute exacerbations of chronic obstructive pulmonary disease: diagnosis, management, and prevention in critically ill patients.
    Dixit D; Bridgeman MB; Andrews LB; Narayanan N; Radbel J; Parikh A; Sunderram J
    Pharmacotherapy; 2015 Jun; 35(6):631-48. PubMed ID: 26032691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short- Versus Standard-Course Nonmacrolide Antibiotic Treatment in Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Retrospective, Observational Cohort Study.
    Betthauser KD; Eble LN; Juang P; Lizza BD; Micek ST; Kollef MH
    Clin Ther; 2021 Nov; 43(11):1948-1956.e1. PubMed ID: 34736767
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of Macrolide Antibiotics on Hospital Readmissions and Other Clinically Important Outcomes in Critically Ill Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease: A Propensity Score-Matched Cohort Study.
    Kiser TH; Reynolds PM; Moss M; Burnham EL; Ho PM; Vandivier RW;
    Pharmacotherapy; 2019 Mar; 39(3):242-252. PubMed ID: 30663791
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of corticosteroid therapy in patients with an acute exacerbation of chronic obstructive pulmonary disease receiving ventilatory support.
    Alía I; de la Cal MA; Esteban A; Abella A; Ferrer R; Molina FJ; Torres A; Gordo F; Elizalde JJ; de Pablo R; Huete A; Anzueto A
    Arch Intern Med; 2011 Nov; 171(21):1939-46. PubMed ID: 22123804
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Corticosteroids in the treatment of acute exacerbations of chronic obstructive pulmonary disease.
    Woods JA; Wheeler JS; Finch CK; Pinner NA
    Int J Chron Obstruct Pulmon Dis; 2014; 9():421-30. PubMed ID: 24833897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different durations of corticosteroid therapy for exacerbations of chronic obstructive pulmonary disease.
    Walters JA; Tan DJ; White CJ; Wood-Baker R
    Cochrane Database Syst Rev; 2014 Dec; (12):CD006897. PubMed ID: 25491891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of corticosteroids on the duration of ventilatory support during severe acute exacerbations of chronic obstructive pulmonary disease in patients in the intensive care unit: a study protocol for a multicentre, randomized, placebo-controlled, double-blind trial.
    Ferré A; Thille AW; Mekontso-Dessap A; Similowski T; Legriel S; Aegerter P; Demoule A;
    Trials; 2023 Mar; 24(1):231. PubMed ID: 36967375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of corticosteroid use in outpatient treatment of exacerbated COPD - Study protocol for a randomized, double-blind, non-inferiority study, (The RECUT-trial).
    Urwyler P; Boesing M; Abig K; Cattaneo M; Dieterle T; Zeller A; Bachler H; Markun S; Senn O; Merlo C; Essig S; Ullmer E; Rutishauser J; Schuurmans MM; Leuppi JD
    Trials; 2019 Dec; 20(1):727. PubMed ID: 31842993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of corticosteroid dose and route of administration with risk of treatment failure in acute exacerbation of chronic obstructive pulmonary disease.
    Lindenauer PK; Pekow PS; Lahti MC; Lee Y; Benjamin EM; Rothberg MB
    JAMA; 2010 Jun; 303(23):2359-67. PubMed ID: 20551406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Corticosteroids for severe acute exacerbations of chronic obstructive pulmonary disease in intensive care: From the French OUTCOMEREA cohort.
    Galerneau LM; Bailly S; Terzi N; Ruckly S; Garrouste-Orgeas M; Cohen Y; Hong Tuan Ha V; Gainnier M; Siami S; Dupuis C; Darmon M; Azoulay E; Forel JM; Sigaud F; Adrie C; Goldgran-Toledano D; Ferré A; de Montmollin E; Argaud L; Reignier J; Pepin JL; Timsit JF;
    PLoS One; 2023; 18(4):e0284591. PubMed ID: 37075003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Personalized Variable vs Fixed-Dose Systemic Corticosteroid Therapy in Hospitalized Patients With Acute Exacerbations of COPD: A Prospective, Multicenter, Randomized, Open-Label Clinical Trial.
    Li L; Zhao N; Ma X; Sun F; He B; Qin Z; Wu K; Wang X; Zhao Q; Zhang S; Nie N; Luo D; Sun B; Shen Y; He Y; Wen F; Zheng J; Jones P; Cao G
    Chest; 2021 Nov; 160(5):1660-1669. PubMed ID: 34023318
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness and Safety Comparison for Systemic Corticosteroid Therapy With and Without Inhaled Corticosteroids for COPD Exacerbation Management.
    Pearce JA; Shiltz DL; Ding Q
    Ann Pharmacother; 2018 Nov; 52(11):1070-1077. PubMed ID: 29783858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hospitalization with acute exacerbation of chronic obstructive pulmonary disease and associated health resource utilization: a population-based Danish cohort study.
    Johannesdottir SA; Christiansen CF; Johansen MB; Olsen M; Xu X; Parker JM; Molfino NA; Lash TL; Fryzek JP
    J Med Econ; 2013 Jul; 16(7):897-906. PubMed ID: 23621504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroids for hospitalized patients with mild to critically-ill COVID-19: a multicenter, retrospective, propensity score-matched study.
    Ikeda S; Misumi T; Izumi S; Sakamoto K; Nishimura N; Ro S; Fukunaga K; Okamori S; Tachikawa N; Miyata N; Shinkai M; Shinoda M; Miyazaki Y; Iijima Y; Izumo T; Inomata M; Okamoto M; Yamaguchi T; Iwabuchi K; Masuda M; Takoi H; Oyamada Y; Fujitani S; Mineshita M; Ishii H; Nakagawa A; Yamaguchi N; Hibino M; Tsushima K; Nagai T; Ishikawa S; Ishikawa N; Kondoh Y; Yamazaki Y; Gocho K; Nishizawa T; Tsuzuku A; Yagi K; Shindo Y; Takeda Y; Yamanaka T; Ogura T
    Sci Rep; 2021 May; 11(1):10727. PubMed ID: 34021229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease: hospital and intensive care unit outcomes in the Kingdom of Saudi Arabia.
    Alaithan AM; Memon JI; Rehmani RS; Qureshi AA; Salam A
    Int J Chron Obstruct Pulmon Dis; 2012; 7():819-23. PubMed ID: 23269866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and Outcomes of Critically Ill Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Australia and New Zealand.
    Berenyi F; Steinfort DP; Abdelhamid YA; Bailey MJ; Pilcher DV; Bellomo R; Finnis ME; Young PJ; Deane AM
    Ann Am Thorac Soc; 2020 Jun; 17(6):736-745. PubMed ID: 32135066
    [No Abstract]   [Full Text] [Related]  

  • 20. Exacerbation recovery patterns in newly diagnosed or maintenance treatment-naïve patients with COPD: secondary analyses of TICARI 1 trial data.
    Mannino DM; Clerisme-Beaty EM; Franceschina J; Ting N; Leidy NK
    Int J Chron Obstruct Pulmon Dis; 2018; 13():1515-1525. PubMed ID: 29785101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.